Multiple Sclerosis & Immune Disorders

Filter Your Results

 

News

 

A Treatment Within

A Q&A with Roland Martin, MD

July/August 2013—A small Phase I trial sees success using patients’ own altered blood cells to fight immune responses in MS. Is this the future of MS therapy?

Emerging Options from the MS Treatment Pipeline

Zac Haughn, Senior Associate Editor

July/August 2012—The MS pipeline is full of potential. Which therapies will be on the front line in tomorrow’s battle against MS?

Relapsing and Progressive Multiple Sclerosis: Understanding the Differences

Flavia Nelson, MD

July/August 2012—Accurate diagnosis is important in order to adjust treatment according to MS type as wells as individual response.

Pathway to Success? MS Drug Takes Nrf-2 Pathway for Treatment

Zac Haughn, Senior Associate Editor

May/June 2012—BG-12 is an oral therapy under regulatory review in the US and Europe for the treatment of MS.

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.

 
  • BRYN MAWR COMMUNICATIONS III, LLC